Details
Stereochemistry | MIXED |
Molecular Formula | C14H32N2O4 |
Molecular Weight | 292.4149 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 0 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(O)CN(CCN(CC(C)O)CC(C)O)CC(C)O
InChI
InChIKey=NSOXQYCFHDMMGV-UHFFFAOYSA-N
InChI=1S/C14H32N2O4/c1-11(17)7-15(8-12(2)18)5-6-16(9-13(3)19)10-14(4)20/h11-14,17-20H,5-10H2,1-4H3
Quadrol, N,N,N',N'-tetrakis(2-hydroxypropyl)ethylenediamine, also known as edetol, is a registered trademark of BASF Corporation. Quadrol has proven to be an excellent cross-linking agent and catalyst for use in polyurethane coatings and rigid foams. The four hydroxyl groups in quadrol give multiple cross-linking sites and the two tertiary nitrogen atoms provide catalysis for the reaction. In addition, was studied the biological activity of quadrol: this compound promoted in vivo collagen synthesis and was effective as a stimulator of wound healing in diabetic and non-diabetic animals. Quadrol exists as a mixture of four unique diastereomers, each of which may display differences in biological activity.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
The behavior of organic components in copper recovery from electroless plating bath effluents using 3D electrode systems. | 2004 Aug 30 |
|
Magnetic resonance flow velocity and temperature mapping of a shape memory polymer foam device. | 2009 Dec 31 |
|
Sorption of Cu(II) complexes with ligands tartrate, glycine and quadrol by chitosan. | 2009 Nov 15 |
|
Decontamination of solutions containing Cu(II) and ligands tartrate, glycine and quadrol using metallic iron. | 2010 Mar 15 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3246540
normal and diabetic mice: the rate of collagen deposition in implanted polytetrafluoroethylene (PTFE) tubing in non-diabetic and streptozotocin-induced (STZ) diabetic mice was measured during 14 days post-wounding. At the time of implantation, test groups received injections of either quadrol (edetol; N,N,N',N'-tetrakis(2-hydroxypropyl)ethylenediamine], glucan, or buffer in an area adjacent to the wound site. Quadrol promotes in vivo collagen synthesis and that quadrol may be effective as a stimulator of wound healing in diabetic and non-diabetic animals.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4056411
Curator's Comment: Mouse peritoneal macrophages, when exposed to Quadrol [N,N,N',N'-tetrakis(2-hydroxypropyl)ethylenediamine/edetol] in vitro, show a dose dependent enhanced spreading over a four-hour period. The rate and extent of the enhancement of phagocytosis was comparable to that observed for lipopolysaccharide and tuftsin.
Unknown
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
5313
Created by
admin on Fri Dec 15 17:41:18 GMT 2023 , Edited by admin on Fri Dec 15 17:41:18 GMT 2023
|
PRIMARY | |||
|
5349
Created by
admin on Fri Dec 15 17:41:18 GMT 2023 , Edited by admin on Fri Dec 15 17:41:18 GMT 2023
|
PRIMARY | |||
|
T-71
Created by
admin on Fri Dec 15 17:41:18 GMT 2023 , Edited by admin on Fri Dec 15 17:41:18 GMT 2023
|
PRIMARY | |||
|
Q4R969U9FR
Created by
admin on Fri Dec 15 17:41:18 GMT 2023 , Edited by admin on Fri Dec 15 17:41:18 GMT 2023
|
PRIMARY | |||
|
Q4R969U9FR
Created by
admin on Fri Dec 15 17:41:18 GMT 2023 , Edited by admin on Fri Dec 15 17:41:18 GMT 2023
|
PRIMARY | |||
|
102-60-3
Created by
admin on Fri Dec 15 17:41:18 GMT 2023 , Edited by admin on Fri Dec 15 17:41:18 GMT 2023
|
PRIMARY | |||
|
C76706
Created by
admin on Fri Dec 15 17:41:18 GMT 2023 , Edited by admin on Fri Dec 15 17:41:18 GMT 2023
|
PRIMARY | |||
|
CHEMBL1573178
Created by
admin on Fri Dec 15 17:41:18 GMT 2023 , Edited by admin on Fri Dec 15 17:41:18 GMT 2023
|
PRIMARY | |||
|
203-041-4
Created by
admin on Fri Dec 15 17:41:18 GMT 2023 , Edited by admin on Fri Dec 15 17:41:18 GMT 2023
|
PRIMARY | |||
|
m4923
Created by
admin on Fri Dec 15 17:41:18 GMT 2023 , Edited by admin on Fri Dec 15 17:41:18 GMT 2023
|
PRIMARY | Merck Index | ||
|
SUB06457MIG
Created by
admin on Fri Dec 15 17:41:18 GMT 2023 , Edited by admin on Fri Dec 15 17:41:18 GMT 2023
|
PRIMARY | |||
|
100000080491
Created by
admin on Fri Dec 15 17:41:18 GMT 2023 , Edited by admin on Fri Dec 15 17:41:18 GMT 2023
|
PRIMARY | |||
|
DTXSID9026689
Created by
admin on Fri Dec 15 17:41:18 GMT 2023 , Edited by admin on Fri Dec 15 17:41:18 GMT 2023
|
PRIMARY | |||
|
1314349
Created by
admin on Fri Dec 15 17:41:18 GMT 2023 , Edited by admin on Fri Dec 15 17:41:18 GMT 2023
|
PRIMARY | RxNorm | ||
|
7615
Created by
admin on Fri Dec 15 17:41:18 GMT 2023 , Edited by admin on Fri Dec 15 17:41:18 GMT 2023
|
PRIMARY | |||
|
369219
Created by
admin on Fri Dec 15 17:41:18 GMT 2023 , Edited by admin on Fri Dec 15 17:41:18 GMT 2023
|
PRIMARY | |||
|
C45678
Created by
admin on Fri Dec 15 17:41:18 GMT 2023 , Edited by admin on Fri Dec 15 17:41:18 GMT 2023
|
CONCEPT | Industrial Aid |
ACTIVE MOIETY